JP Stock MarketDetailed Quotes

2395 Shin Nippon Biomedical Laboratories

Watchlist

1597
+43+2.77%

20min DelayMarket Closed Nov 29 15:30 JST

66.49BMarket Cap12.02P/E (Static)

Shin Nippon Biomedical Laboratories Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

Total revenue

-4.40%5.55B

5.42%26.45B

-2.91%8.47B

1.29%6.1B

-3.54%6.08B

43.46%5.8B

41.37%25.09B

81.56%8.72B

20.83%6.02B

28.09%6.3B

Cost of revenue

-3.31%2.52B

1.03%12.17B

-13.87%3.72B

4.87%2.92B

-1.09%2.92B

31.11%2.61B

49.41%12.04B

102.18%4.32B

21.79%2.78B

36.50%2.95B

Gross profit

-5.29%3.02B

9.47%14.28B

7.85%4.75B

-1.78%3.18B

-5.70%3.16B

55.42%3.19B

34.68%13.05B

65.04%4.4B

20.01%3.24B

21.49%3.35B

Operating expense

61.18%3.17B

29.72%10.12B

6.13%3.12B

69.23%3B

16.36%2.04B

46.67%1.97B

42.06%7.8B

65.94%2.94B

29.31%1.77B

36.76%1.75B

Staff costs

----

12.55%3.26B

----

19.75%2.9B

----

Selling and administrative expenses

----

43.25%1.93B

----

34.74%1.35B

----

-General and administrative expense

----

43.25%1.93B

----

34.74%1.35B

----

Research and development costs

----

154.91%1.74B

----

60.69%683.07M

----

Depreciation and amortization

----

16.33%261.37M

----

41.34%224.68M

----

-Depreciation

----

16.33%261.37M

----

41.34%224.68M

----

Rent and land expenses

----

16.50%159.78M

----

31.27%137.15M

----

Other operating expenses

----

10.14%2.77B

----

81.49%2.51B

----

Operating profit

-111.83%-145.19M

-20.64%4.16B

11.31%1.63B

-87.33%186.25M

-29.84%1.12B

71.86%1.23B

25.02%5.25B

63.26%1.46B

10.45%1.47B

8.27%1.6B

Net non-operating interest income (expenses)

-4.93%-38.26M

170.61%47.78M

1,020.54%68.84M

-50.24%-43.76M

451.54%59.16M

-30.92%-36.46M

42.82%-67.66M

124.44%6.14M

-11.15%-29.13M

47.83%-16.83M

Non-operating interest income

373.61%2.3M

225.01%186.56M

172.11%110.76M

-5,042.78%-9.59M

438.05%84.9M

-33.01%485K

590.50%57.4M

1,214.70%40.7M

-94.01%194K

1,120.42%15.78M

Non-operating interest expense

9.77%40.56M

10.97%138.78M

21.30%41.92M

16.54%34.17M

-21.04%25.75M

29.30%36.95M

-1.25%125.06M

22.40%34.56M

-0.42%29.32M

-2.80%32.61M

Net investment income

-197.20%-281.88M

-95.87%62.44M

-167.32%-219.2M

102.69%37.73M

-105.12%-46.09M

-82.81%289.99M

10.34%1.51B

-62.98%325.6M

-514.18%-1.4B

461.66%899.61M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

97.70%-31.36M

64.62%-31.36M

-3,554.64%-1.36B

-137.96%-88.62M

-1.2B

Income from associates and other participating interests

44.58%768.99M

10.55%2.75B

19.56%603.65M

4.25%908.31M

-5.10%707.97M

44.93%531.88M

41.29%2.49B

-14.59%504.89M

88.24%871.25M

286.77%746.04M

Special income (charges)

-148.49%-31.03M

86.22%-10.12M

34.12%-63.52M

65.03%-3.97M

-119.02%-6.62M

14,510.81%63.98M

-108.95%-73.42M

55.85%-96.42M

27.63%-11.35M

58.55%34.79M

Less:Restructuring and mergern&acquisition

--0

---82.16M

--0

---82.16M

--0

Less:Other special charges

85.41%29.91M

98.36%57.66M

-37.84%32.75M

-71.16%3.27M

115.80%5.5M

9,266.48%16.13M

102.78%29.07M

2,361.96%52.69M

-11.27%11.35M

-58.55%-34.79M

Less:Write off

-45.53%1.12M

-21.93%34.63M

-29.65%30.77M

--695K

--1.12M

230.16%2.05M

-80.30%44.36M

-79.77%43.74M

--0

Other non-operating income (expenses)

128.46%38.45M

-155.60%-8.46M

224.54%51.75M

-0.65%39.27M

149.33%35.63M

-522.62%-135.11M

-92.04%15.21M

-70.21%15.95M

-18.95%39.53M

-223.90%-72.23M

Income before tax

-83.98%311.09M

-10.12%6.97B

-4.33%2.04B

533.62%1.12B

-39.94%1.87B

-29.96%1.94B

-5.18%7.76B

-0.45%2.13B

-112.12%-259.18M

65.97%3.12B

Income tax

-64.87%196.68M

-14.76%1.46B

-25.22%323.82M

235.19%292.54M

-57.30%280.49M

-32.97%559.88M

68.17%1.71B

90.98%433.05M

-155.92%-216.39M

222.22%656.95M

Net income

-91.72%114.41M

-8.81%5.52B

1.01%1.71B

2,043.06%831.3M

-35.31%1.59B

-28.67%1.38B

-15.58%6.05B

-11.29%1.7B

-102.44%-42.78M

46.94%2.46B

Net income continuous operations

-91.72%114.41M

-8.81%5.52B

1.01%1.71B

2,043.01%831.3M

-35.31%1.59B

-28.67%1.38B

-15.58%6.05B

-11.29%1.7B

-102.44%-42.78M

46.94%2.46B

Noncontrolling interests

-195.18%-7.79M

-44.98%-13.55M

-90.13%-23.65M

-88.85%2.82M

93.81%-898K

206.47%8.18M

-123.68%-9.35M

-138.82%-12.44M

228.60%25.29M

-493.74%-14.51M

Net income attributable to the company

-91.10%122.19M

-8.73%5.53B

1.66%1.74B

1,317.10%828.48M

-35.65%1.59B

-29.37%1.37B

-14.98%6.06B

-9.12%1.71B

-103.90%-68.07M

47.60%2.48B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-91.10%122.19M

-8.73%5.53B

1.66%1.74B

1,317.10%828.48M

-35.65%1.59B

-29.37%1.37B

-14.98%6.06B

-9.12%1.71B

-103.90%-68.07M

47.60%2.48B

Gross dividend payment

Basic earnings per share

-91.12%2.93

-8.72%132.86

1.66%41.72

1,313.41%19.9

-35.65%38.26

-29.38%32.98

-14.98%145.56

-9.10%41.04

-103.91%-1.64

47.62%59.46

Diluted earnings per share

-91.12%2.93

-8.72%132.86

1.66%41.7135

1,313.41%19.9

-35.65%38.26

-29.38%32.98

-14.98%145.56

-9.12%41.0334

-103.91%-1.64

47.62%59.46

Dividend per share

0.00%50

0.00%30

0.00%20

66.67%50

0.00%30

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022
Total revenue	-4.40%5.55B	5.42%26.45B	-2.91%8.47B	1.29%6.1B	-3.54%6.08B	43.46%5.8B	41.37%25.09B	81.56%8.72B	20.83%6.02B	28.09%6.3B
Cost of revenue	-3.31%2.52B	1.03%12.17B	-13.87%3.72B	4.87%2.92B	-1.09%2.92B	31.11%2.61B	49.41%12.04B	102.18%4.32B	21.79%2.78B	36.50%2.95B
Gross profit	-5.29%3.02B	9.47%14.28B	7.85%4.75B	-1.78%3.18B	-5.70%3.16B	55.42%3.19B	34.68%13.05B	65.04%4.4B	20.01%3.24B	21.49%3.35B
Operating expense	61.18%3.17B	29.72%10.12B	6.13%3.12B	69.23%3B	16.36%2.04B	46.67%1.97B	42.06%7.8B	65.94%2.94B	29.31%1.77B	36.76%1.75B
Staff costs	----	12.55%3.26B	----	----	----	----	19.75%2.9B	----	----	----
Selling and administrative expenses	----	43.25%1.93B	----	----	----	----	34.74%1.35B	----	----	----
-General and administrative expense	----	43.25%1.93B	----	----	----	----	34.74%1.35B	----	----	----
Research and development costs	----	154.91%1.74B	----	----	----	----	60.69%683.07M	----	----	----
Depreciation and amortization	----	16.33%261.37M	----	----	----	----	41.34%224.68M	----	----	----
-Depreciation	----	16.33%261.37M	----	----	----	----	41.34%224.68M	----	----	----
Rent and land expenses	----	16.50%159.78M	----	----	----	----	31.27%137.15M	----	----	----
Other operating expenses	----	10.14%2.77B	----	----	----	----	81.49%2.51B	----	----	----
Operating profit	-111.83%-145.19M	-20.64%4.16B	11.31%1.63B	-87.33%186.25M	-29.84%1.12B	71.86%1.23B	25.02%5.25B	63.26%1.46B	10.45%1.47B	8.27%1.6B
Net non-operating interest income (expenses)	-4.93%-38.26M	170.61%47.78M	1,020.54%68.84M	-50.24%-43.76M	451.54%59.16M	-30.92%-36.46M	42.82%-67.66M	124.44%6.14M	-11.15%-29.13M	47.83%-16.83M
Non-operating interest income	373.61%2.3M	225.01%186.56M	172.11%110.76M	-5,042.78%-9.59M	438.05%84.9M	-33.01%485K	590.50%57.4M	1,214.70%40.7M	-94.01%194K	1,120.42%15.78M
Non-operating interest expense	9.77%40.56M	10.97%138.78M	21.30%41.92M	16.54%34.17M	-21.04%25.75M	29.30%36.95M	-1.25%125.06M	22.40%34.56M	-0.42%29.32M	-2.80%32.61M
Net investment income	-197.20%-281.88M	-95.87%62.44M	-167.32%-219.2M	102.69%37.73M	-105.12%-46.09M	-82.81%289.99M	10.34%1.51B	-62.98%325.6M	-514.18%-1.4B	461.66%899.61M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets		97.70%-31.36M	64.62%-31.36M	0			-3,554.64%-1.36B	-137.96%-88.62M	-1.2B
Income from associates and other participating interests	44.58%768.99M	10.55%2.75B	19.56%603.65M	4.25%908.31M	-5.10%707.97M	44.93%531.88M	41.29%2.49B	-14.59%504.89M	88.24%871.25M	286.77%746.04M
Special income (charges)	-148.49%-31.03M	86.22%-10.12M	34.12%-63.52M	65.03%-3.97M	-119.02%-6.62M	14,510.81%63.98M	-108.95%-73.42M	55.85%-96.42M	27.63%-11.35M	58.55%34.79M
Less:Restructuring and mergern&acquisition	--0	---82.16M	--0	--0	--0	---82.16M	--0	--0	--0	--0
Less:Other special charges	85.41%29.91M	98.36%57.66M	-37.84%32.75M	-71.16%3.27M	115.80%5.5M	9,266.48%16.13M	102.78%29.07M	2,361.96%52.69M	-11.27%11.35M	-58.55%-34.79M
Less:Write off	-45.53%1.12M	-21.93%34.63M	-29.65%30.77M	--695K	--1.12M	230.16%2.05M	-80.30%44.36M	-79.77%43.74M	--0	--0
Other non-operating income (expenses)	128.46%38.45M	-155.60%-8.46M	224.54%51.75M	-0.65%39.27M	149.33%35.63M	-522.62%-135.11M	-92.04%15.21M	-70.21%15.95M	-18.95%39.53M	-223.90%-72.23M
Income before tax	-83.98%311.09M	-10.12%6.97B	-4.33%2.04B	533.62%1.12B	-39.94%1.87B	-29.96%1.94B	-5.18%7.76B	-0.45%2.13B	-112.12%-259.18M	65.97%3.12B
Income tax	-64.87%196.68M	-14.76%1.46B	-25.22%323.82M	235.19%292.54M	-57.30%280.49M	-32.97%559.88M	68.17%1.71B	90.98%433.05M	-155.92%-216.39M	222.22%656.95M
Net income	-91.72%114.41M	-8.81%5.52B	1.01%1.71B	2,043.06%831.3M	-35.31%1.59B	-28.67%1.38B	-15.58%6.05B	-11.29%1.7B	-102.44%-42.78M	46.94%2.46B
Net income continuous operations	-91.72%114.41M	-8.81%5.52B	1.01%1.71B	2,043.01%831.3M	-35.31%1.59B	-28.67%1.38B	-15.58%6.05B	-11.29%1.7B	-102.44%-42.78M	46.94%2.46B
Noncontrolling interests	-195.18%-7.79M	-44.98%-13.55M	-90.13%-23.65M	-88.85%2.82M	93.81%-898K	206.47%8.18M	-123.68%-9.35M	-138.82%-12.44M	228.60%25.29M	-493.74%-14.51M
Net income attributable to the company	-91.10%122.19M	-8.73%5.53B	1.66%1.74B	1,317.10%828.48M	-35.65%1.59B	-29.37%1.37B	-14.98%6.06B	-9.12%1.71B	-103.90%-68.07M	47.60%2.48B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-91.10%122.19M	-8.73%5.53B	1.66%1.74B	1,317.10%828.48M	-35.65%1.59B	-29.37%1.37B	-14.98%6.06B	-9.12%1.71B	-103.90%-68.07M	47.60%2.48B
Gross dividend payment
Basic earnings per share	-91.12%2.93	-8.72%132.86	1.66%41.72	1,313.41%19.9	-35.65%38.26	-29.38%32.98	-14.98%145.56	-9.10%41.04	-103.91%-1.64	47.62%59.46
Diluted earnings per share	-91.12%2.93	-8.72%132.86	1.66%41.7135	1,313.41%19.9	-35.65%38.26	-29.38%32.98	-14.98%145.56	-9.12%41.0334	-103.91%-1.64	47.62%59.46
Dividend per share	0	0.00%50	0.00%30	0	0.00%20	0	66.67%50	0.00%30	0	20
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data